Cytomed Therapeutics Ltd. (GDTC)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 11
-0.04
-3.4783%
$
13.49M Market Cap
- P/E Ratio
- Div Yield
1,622 Volume
-0.26 Eps
$ 1.15
Previous Close Want to track GDTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
GDTC Earnings Reports FAQ
What is the earnings per share (EPS) for GDTC?
The current EPS is -0.26.
What is the company's earnings growth rate?
Cytomed Therapeutics Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Cytomed Therapeutics Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Cytomed Therapeutics Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GDTC at this time, as Cytomed Therapeutics Ltd has no recent EPS data to calculate it.
